Toll Free: 1-888-928-9744
Published: May, 2015 | Pages:
25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Charlesson LLC. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Charlesson LLC. - Product Pipeline Review - 2015', provides an overview of the Charlesson LLC.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Charlesson LLC.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Charlesson LLC. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Charlesson LLC.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Charlesson LLC.'s pipeline products Reasons to buy - Evaluate Charlesson LLC.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Charlesson LLC. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Charlesson LLC.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Charlesson LLC. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Charlesson LLC. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Charlesson LLC. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Charlesson LLC. Snapshot 5 Charlesson LLC. Overview 5 Key Information 5 Key Facts 5 Charlesson LLC. - Research and Development Overview 6 Key Therapeutic Areas 6 Charlesson LLC. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Charlesson LLC. - Pipeline Products Glance 10 Charlesson LLC. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Discovery Products/Combination Treatment Modalities 11 Charlesson LLC. - Drug Profiles 12 CLT-005 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 CLT-010 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 CLT-01001 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 CLT-01007 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CLT-01012 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 E-1086 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Charlesson LLC. - Pipeline Analysis 18 Charlesson LLC. - Pipeline Products by Target 18 Charlesson LLC. - Pipeline Products by Route of Administration 19 Charlesson LLC. - Pipeline Products by Molecule Type 20 Charlesson LLC. - Pipeline Products by Mechanism of Action 21 Charlesson LLC. - Dormant Projects 22 Charlesson LLC. - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 24 Disclaimer 25
List of Tables Charlesson LLC., Key Information 5 Charlesson LLC., Key Facts 5 Charlesson LLC. - Pipeline by Indication, 2015 7 Charlesson LLC. - Pipeline by Stage of Development, 2015 8 Charlesson LLC. - Monotherapy Products in Pipeline, 2015 9 Charlesson LLC. - Preclinical, 2015 10 Charlesson LLC. - Discovery, 2015 11 Charlesson LLC. - Pipeline by Target, 2015 18 Charlesson LLC. - Pipeline by Route of Administration, 2015 19 Charlesson LLC. - Pipeline by Molecule Type, 2015 20 Charlesson LLC. - Pipeline Products by Mechanism of Action, 2015 21 Charlesson LLC. - Dormant Developmental Projects,2015 22
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.